PARASITOL

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: PARASITOL
Generic name: PYRANTEL PAMOATE
Manufacturer: Menper Distributors Inc.
Product type: HUMAN OTC DRUG
SPL set ID: cd5eb4c9-d0f0-4be7-84eb-88ebc4632dc6
SPL ID: 3a8a63ea-ec4f-58e7-e063-6394a90a3110
Version: 4
Effective date: 2025-07-22
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:32

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M024	openfda.application_number
brand name		PARASITOL	openfda.brand_name
generic name		PYRANTEL PAMOATE	openfda.generic_name
manufacturer name		Menper Distributors Inc.	openfda.manufacturer_name
ndc	package	53145-101-01	openfda.package_ndc
ndc	package	53145-101-11	openfda.package_ndc
ndc	product	53145-101	openfda.product_ndc
ndc11	package	53145010111	derived:openfda.package_ndc
ndc11	package	53145010101	derived:openfda.package_ndc
rxcui		199106	openfda.rxcui
spl id		3a8a63ea-ec4f-58e7-e063-6394a90a3110	id
spl set id		cd5eb4c9-d0f0-4be7-84eb-88ebc4632dc6	set_id
unii		81BK194Z5M	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Do not Exceed recommended usage Whenm using this product abdominal cramps, nausea, vomiting, diarrhea, headache, or dizziness sometimes occur after taking this drug. If any of these conditions persist consult a doctor. Ask a doctor before use if you have liver disease

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.